Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jill F. Blim"'
Publikováno v:
J Vitreoretin Dis
Publikováno v:
J Vitreoretin Dis
Purpose: This work analyzes data from a series of surveys developed by the American Society of Retina Specialists (ASRS) that assesses the impact of COVID-19 on physicians, their practices, and their patients. Methods: Five surveys were sent by the A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f24e0f835fd7c7e4959c5dbba045dff1
https://europepmc.org/articles/PMC9976225/
https://europepmc.org/articles/PMC9976225/
Autor:
Mark S. Humayun, Dana P. Goldman, Jill F. Blim, Karen Mulligan, Seth A. Seabury, Pravin U. Dugel
Publikováno v:
JAMA ophthalmology. 138(1)
Importance Anti–vascular endothelial growth factor (anti-VEGF) is a breakthrough treatment for wet age-related macular degeneration (wAMD), the most common cause of blindness in western countries. Anti-VEGF treatment prevents vision loss and has be
Autor:
Kay Dickersin, Kristina Lindsley, Dan Roberts, Susan Hutfless, Timothy W. Olsen, Flora Lum, Jill F. Blim, Barbara S. Hawkins
Importance Identifying and prioritizing unanswered clinical questions may help to best allocate limited resources for research associated with the treatment of age-related macular degeneration (AMD). Objective To identify and prioritize clinical ques
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b243ccb9b576371aa7cf053f4d404a03
https://europepmc.org/articles/PMC6248173/
https://europepmc.org/articles/PMC6248173/